Pharmaceutical Benefit-Risk Perception and Older Age: A Pilot Study.

Area of Science:

• Pharmaceuticals
• Gerontology
• Health Communication

Background:

• Older age significantly influences perceptions of pharmaceutical benefits and risks.
• Effective communication of these perceptions is challenging for regulatory bodies and patient advocacy groups.
• This study aimed to identify age-related effects in pharmaceutical benefit-risk perception.

Purpose of the Study:

• To explore and compare pharmaceutical benefit-risk perceptions between older and younger adults.
• To identify age-specific factors influencing these perceptions.
• To inform future strategies for risk communication tailored to different age groups.

Main Methods:

• Conducted 80 face-to-face surveys with older and younger adults.
• Included participants from Boulder, Colorado (USA) and Dublin (Ireland).
• Assessed perceptions of risks and benefits for various medical treatments and conditions.

Main Results:

• Older adults perceived greater risks for 14 of 16 items compared to younger adults.
• Both age groups generally viewed medical treatments as high-benefit and low-risk.
• Older adults' risk perception was influenced by personal experiences, emotions, and varied definitions of risk (side effects, misuse, broader issues).

Conclusions:

• Age-related differences in risk perception warrant further investigation.
• Improved understanding can enhance the effectiveness of pharmaceutical benefit-risk communication for all adults.
• Personal experiences and emotional associations significantly shape older adults' benefit-risk judgments.